Tyra Biosciences Inc. (TYRA)
NASDAQ: TYRA
· Real-Time Price · USD
13.66
0.27 (2.02%)
At close: Oct 03, 2025, 3:59 PM
13.66
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
2.02% (1D)
| Bid | 9.93 |
| Market Cap | 728.02M |
| Revenue (ttm) | 496K |
| Net Income (ttm) | -105.83M |
| EPS (ttm) | -1.79 |
| PE Ratio (ttm) | -7.63 |
| Forward PE | -6.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 17.44 |
| Volume | 96,094 |
| Avg. Volume (20D) | 217,393 |
| Open | 13.88 |
| Previous Close | 13.39 |
| Day's Range | 13.53 - 13.92 |
| 52-Week Range | 6.42 - 29.60 |
| Beta | 1.11 |
| Ex-Dividend Date | n/a |
About TYRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TYRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TYRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+14.26%
Tyra Biosciences shares are trading higher after t...
Unlock content with
Pro Subscription
11 months ago
-23.35%
Tyra Biosciences shares are trading lower. The company announced clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial cancer from its ongoing SURF301 Phase 1/2 study.
